Hemangioma, Capillary clinical trials
The registry lists 35 studies for Hemangioma, Capillary across more than 10 countries. 6 are recruiting or about to start. 33 of them are mainly about Hemangioma, Capillary (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-16.
Get an email when these change. Save the Hemangioma, Capillary studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Who runs them
West China Hospital (8) · The Hospital for Sick Children (2) · Pierre Fabre Dermatology (2) · XiaoXi Lin (1) · University Hospital, Montpellier (1) · Oregon Health and Science University (1) · Central Hospital, Nancy, France (1) · Auson Pharmaceuticals Inc. (1)
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
All 3
- Mar 2027Incidence and Clinical Features of PHACE Syndrome · West China Hospital
- Jun 2027Screening LUMBAR Syndrome in Infants With Infantile Hemangiomas · West China Hospital
- Jun 2027The Incidence and Clinical Characteristics of Infantile Hemangiomas · West China Hospital
Who these studies take
Of the 3 Hemangioma, Capillary studies recruiting now, 0 (0%) set no upper age limit and 3 (100%) stop at 75 or younger. 3 (100%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 1 (33%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 0 (0%) | 0 (0%) |
| 30 | 0 (0%) | 0 (0%) |
| 40 | 0 (0%) | 0 (0%) |
| 50 | 0 (0%) | 0 (0%) |
| 65 | 0 (0%) | 0 (0%) |
| 75 | 0 (0%) | 0 (0%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 35 studies, recruiting or not: 97% stop at 75 or younger and 97% at 65; 100% take children; 0% are for women only and 0% for men only; 17% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
What changed recently
From the registry's own updates since Oct 18, 2026.
Newly registered2
- Incidence and Clinical Features of PHACE SyndromeNov 16, 2026NCT07938710
- The Incidence and Clinical Characteristics of Infantile HemangiomasNov 16, 2026NCT07938723
Studies
Recruiting first, then most recently updated. Showing 35 of 35. search them.
- The Incidence and Clinical Characteristics of Infantile HemangiomasRecruitingNCT079387231 country
- Incidence and Clinical Features of PHACE SyndromeRecruitingNCT079387101 country
- Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested GrowthNot yet recruitingNCT076695451 country
- Abrupt Discontinuation Versus Gradual Tapering of Propranolol in Infantile HemangiomaNot yet recruitingNCT07665177Phase 41 country
- Screening LUMBAR Syndrome in Infants With Infantile HemangiomasNot yet recruitingNCT076163231 country
- Clinical Characteristics of Infantile HemangiomaRecruitingNCT033317441 country
- Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile HemangiomaActive, not recruitingNCT06798363Phase 2/31 country
- Propranolol in Capillary HemangiomasTerminatedNCT00744185Phase 2/31 country
- Oral Propranolol Versus Fractional Carbon Dioxide CO2 Laser Assisted Delivery of Topical Timolol for Treatment of Infantile HemangiomaCompletedNCT07560332Not applicable1 country
- Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile HemangiomasTerminatedNCT05479123Phase 41 country
- Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)CompletedNCT07104526Not applicable1 country
- Timolol Maleate Gel for the Treatment of Infantile HemangiomaCompletedNCT06677853Phase 2/31 country
- Efficacy, Safety and Pharmacokinetics of Topical Timolol in Infants With Infantile Hemangioma (IH)CompletedNCT02913612Phase 21 country
- Efficacy of Intralesional Bleomycin Alone and in Combination With Dexamethasone in Infantile HaemangiomasCompletedNCT06080724Not applicable1 country
- Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of CareCompletedNCT014313265 countries
- Efficacy and Safety of Propranolol Versus Atenolol on the Proliferative Phase of Infantile HemangiomaCompletedNCT02342275Phase 31 country
- Infantile Hemangioma With Minimal or Arrested Growth : Epidemiology, Clinical Characteristics and EvolutionCompletedNCT050808681 country
- Nadolol for Proliferating Infantile HemangiomasCompletedNCT01010308Phase 21 country
- ''Efficacy of Propranolol in the Treatment of Infantile Hemangioma"Status unknownNCT04684667Phase 21 country
- Hemangiol, Post Marketing Surveillance StudyCompletedNCT041055171 country
- Nadolol Versus Propranolol in Children With Infantile HemangiomasCompletedNCT02505971Phase 31 country
- Evaluation of the Efficacy of Captopril Versus Propranolol and Timolol as a Treatment of Infantile Capillary HemangiomaStatus unknownNCT04288700Phase 41 country
- Optimizing Timolol Maleate Treatment of Infantile Hemangioma by Doppler Ultrasound ExaminationStatus unknownNCT038426311 country
- Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile HemangiomasStatus unknownNCT03237637Phase 31 country
- Optical Tomographic Imaging of Infantile HemangiomasCompletedNCT016739711 country
- Genetic Basis of HemangiomasTerminatedNCT004663751 country
- Topical Timolol 0.5% Solution for Proliferating Infantile HemangiomasTerminatedNCT01147601Early Phase 11 country
- A Prospective Study on the Incidence and Related Risk Factors of Infantile Hemangioma in ChinaStatus unknownNCT031733521 country
- Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)TerminatedNCT01434849Phase 11 country
- Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic TherapyCompletedNCT01056341Phase 2/316 countries
- Ontogeny of Infantile Hemangiomas With Skin Imaging ModalitiesCompletedNCT020617351 country
- Study in Infants With Infantile Hemangioma to Compare Propranolol Gel to PlaceboCompletedNCT01512173Phase 23 countries
- Timolol Option for Ulcerated Hemangiomas (TOUCH Trial)WithdrawnNCT01408056Phase 21 country
- Hemangioma Growth During the First 6 Months of LifeCompletedNCT009117811 country
- A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in InfancyCompletedNCT00601016Phase 21 country